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Abstract  
Objective: We report a review of outcomes in schizophrenia in the twenty-first century, replicating 
and extending work undertaken by the late Richard Warner in his seminal book, ‘Recovery from 
Schizophrenia: Psychiatry and Political Economy’ (1985;2004).  
Method: Warner’s methods were followed as closely as possible. Only observational/naturalistic 
studies were included. Six scientific data bases were searched from 2000 to 2020. 6640 records were 
retrieved. 47 met inclusion criteria.  
Results: Overall, complete recovery is higher in this study than in Warner’s (37.75% cf 20.4%), 
especially for first episode psychosis (FEP) (57.1% cf 20.7%). Clinical recovery, annualised remission 
rate (ARR) and employment outcomes were significantly superior for first episode psychosis 
compared with multiple episode psychosis (MEP). ARR shows a trend towards reduction over time, 
from 2.2 before the financial crash of 2008 to 1.6 after (t=1.85 df 40 p=0.07). The decline is 
statistically significant for the MEP group (t=2.32 df18 p=0.03). There were no differences in 
outcome by region, sample characteristics, outcome measures used or quality of studies. 
Heterogeneity of clinical outcome measures across the literature makes evidence synthesis difficult. 
Weak and inconsistent reporting of functional and employment outcomes mean that findings lack 
meaning with respect to lived experience.  
Conclusion: Future research strategies should aim to reduce heterogeneity in clinical outcome 
measures and to increase the emphasis on capture and reporting of more sophisticated measures of 
social and functional outcome. Outcome domains should be disaggregated rather than conflated 
into unitary recovery constructs.  
Key words: Recovery, employment, social outcome, annualised remission rate  
   
   
Summations  
During the 21st century, the trend of improvement in rates of recovery appear to have 
continued, irrespective of how recovery is defined.  
Outcomes for first episode psychosis appear to be far better than for multi-episode psychosis, 
which may be due to improvements in intervention, social attitudes, both, or neither. The 
predominance of multi-episode individuals in Annualised Recovery Rate data may account for 
the paradoxical deterioration in this parameter.  
Changes in the political economy appear to have an immediate impact in slow improvements in 
recovery rates, emphasising the central importance of social factors.  
Limitations  
The studies included are highly heterogenous with respect to definitions of recovery and 
reporting of outcome parameters. Measures of social recovery tend to be crude or omitted 
altogether.  
The degree of heterogeneity in the literature precludes meta-analysis  
All studies included are naturalistic, which improves relevance to clinical practice, but makes 
interpretation of impact of specific factors more difficult.  
   
   
   
   
  
Introduction  
This paper reports a review of outcomes in schizophrenia in the twenty-first century and is 
an extension of the work undertaken by the late Dr Richard Warner in his seminal book, ‘Recovery 
from Schizophrenia: Psychiatry and Political Economy’ (19851; 2004 2). The present work was started 
with Dr Warner’s involvement and the preliminary results were presented at the XVII World 
Congress of Psychiatry in Berlin in 2017. Here we present the final results based on research findings 
published between 2000 and 2020. Initially, we intended to conduct a systematic review and meta-
analysis, but study heterogeneity and paucity of data, including data capture problems and reporting 
weaknesses, means that meta-analysis was not possible. The relevance of these issues is considered 
further below.  
Background  
In 1985, Warner used empirical evidence to strongly challenge the prevailing view of 
schizophrenia, which largely arose through the influence of Kraepelin3, who suggested that psychosis 
was strongly characterised by poor clinical and social outcomes. Since then, evidence from 
epidemiological, sociological, psychological and biological studies have made many aspects of the 
Kraepelinian model of schizophrenia unsustainable4. Few hold to the concept of schizophrenia as a 
unitary disorder, or even, as Bleuler suggested when he coined the term, a distinct group of 
psychoses.5  
Richard Warner was one of the first to systematically bring together and analyse data from 
outcome studies of schizophrenia in the twentieth century. Although we (and others) regularly refer 
to his work in the 2004 edition of Recovery from Schizophrenia, it is important to remember that the 
first edition was published in 1985, almost two decades earlier.  He was interested in shedding light 
on whether “schizophrenia is an inherently catastrophic illness from which only modern psychiatric 
treatment can afford relief; or that it is a condition with a considerable spontaneous recovery rate 
upon which treatment has little long-term effect.” (p.60). Most importantly, he showed that 
conditions such as social and political attitudes and the state of the economy, “mould the course and 
outcome of the illness and influence, along with other factors, its incidence.” (p. xii) and by 
implication, outcome. Subsequent work has confirmed his challenge to the Kraepelinian notion of a 
dementia-like psychotic process, mainly determined by biological factors. His work has 
contemporary relevance.  
Warner distinguished between “complete recovery” and “social recovery”. He defined the 
former as loss of psychiatric symptoms and return to pre-illness level of functioning, where as he 
defined social recovery in functional terms;  economic and residential independence with low social 
disruption, an important component of which is employment. 
Since Warner’s 1985 edition of Recovery from Schizophrenia, there has been intense debate 
over the concept of recovery. In particular, there has been controversy over the ownership of 
definitions of recovery; the preferred model of patient self-definition of recovery creates 
methodological problems for quantitative researchers whereas the emergence of a “Recovery 
Model” in statutory services has led to accusations that service definitions of “recovery” are 
sometimes euphemisms for withholding care and treatment. Consequently, the literature is marked 
by a variety of definitions of ‘recovery’, ‘complete recovery’ and ‘partial recovery’, some of which 
are agreed by some groups of researchers, some of which are idiosyncratic6-8  . We must 
acknowledge the existence of these differences and their impact on our conclusions  
   
Warner9 provided a neat attempt to weave the scientific and experiential approaches to 
‘recovery’ together. He rightly pointed out that ‘the proportion of patients considered to have 
recovered will depend on how rigorously recovery is defined’ (p61). A number of issues of definition 
are of significance here. First, it seems to us that to combine both clinical remission and social 
function into a single recovery definition is not helpful and risks the loss of important outcome 
information. As Warner himself said, measures of social functioning are hard to standardise, and can 
cover a wide range of behaviours and activities. In the experiential approach to recovery, individuals 
value different behaviours and activities (work, family contact etc) differently and the importance 
attributed to them may vary overtime. Warner hypothesised that social environment had a 
profound effect on the outcome of psychosis, so that circumstances that support people to social 
inclusion led to a virtuous cycle of improved well-being. This being the case, his thesis was that the 
political economy is a key modifiable factor in improving rates of recovery.  In line with this, we 
believe that employment status ought to receive more attention as an outcome indicator. This is not 
without its difficulties, which we mention later. Nevertheless, we have included employment 
outcomes in this review.  
Second, with regard to the rigour of the definition, it is the case that the length of  ‘recovery’ 
needs to be defined. Warner himself did not include an explicit time criterion in his definition, 
although a 12 month criterion was implicit in his selection of studies.  Although the Remission17 
criteria for proposed evidence-based and consensus-based criteria for defining clinical remission 
does include a 6-month time criterion, this is not adhered to in all studies.  
We believe that the most satisfactory definition of “complete recovery” is clinical remission 
and sustained functional outcomes, which should include employment, for at least 6 months, but it 
is in the nature of a review of this sort that the relevant information is not always available in the 
public domain.  
In his most recent review, Warner included 114 studies from the 1880s to 2004. He found 
that recovery rates overall were little changed since the 1900s. In the last period of his review 
between 1976 and 1995, he separately reported on clinical recovery and social recovery for people 
with first episodes of psychosis (FEP) and for those who experienced multiple episodes of psychosis 
(MEP).  In MEP, the mean complete recovery rate was 20% and social recovery 33%, which was not 
very different from the overall recovery rate from 1901 to 1910 (20% and 41% respectively). In FEP 
recovery occurred in 27%, and social recovery in 35%; higher compared to the earliest figure he gave 
(for the years 1921-1940) which were 12% and 28% respectively. He was unable to present detailed 
findings for what he termed ‘the developing world’ (that is, low- and middle-income countries or 
LMICs), but he did break down the USA and UK results. From 1976 to 1995, complete recovery 
occurred in 17% in the USA and 19% in the UK, while social recovery in the USA was 43% and in the 
UK 30%.  
Since Warner’s work there have been several reviews, some of which report pooled 
outcomes10-12, and two reviews of reviews13,14. The reviews reporting pooled outcome data use very 
different methodologies. In fact, the heterogeneity that scholars bemoan in individual outcome 
studies is equally present in the reviews (cited chronologically in the Supplementary Material A). For 
instance, Menezes 15 did not require included studies to report both clinical remission and social 
outcome, and did not specify a time period for outcomes. Clemmensen et al.16 looked at FEP and 
included patients with mood and other disorders (mixed samples) and as well as some retrospective 
studies, hospital discharge and outpatient samples.  The studies were categorized as reporting 
outcome by use of both the General Functioning Scale (GFS) and study-specific functioning (SSF) 
outcomes. The GFS studies were categorized by the study authors  as a “poor” outcome (score ≤ 50), 
“moderate” outcome (score 51–70), or “good” outcome (score >70) but there was no consistency  in 
the use of these precise cut off points across all studies. The authors subjectively and independently 
rated the SSF outcome data in the papers as “poor,” “moderate,” or “good”.  
In 2003, the Remission in Schizophrenia Working Group (RSWG)17 proposed evidence-based 
and consensus-based criteria for defining clinical remission. Remission was defined as “a level of 
core symptoms (positive, negative and disorganised) that does not interfere with an individual’s 
behaviour, and is also below that required for an initial diagnosis of schizophrenia to be made 
according to the Diagnostic and Statistical Manual of Mental Disorder, fourth edition (DSM-IV)”18 . 
AlAqeel and Margoleses’ review 19 used the RSWG criteria and included only those papers that 
provided data with a minimum six-month follow-up of patients—the length of follow-up originally 
suggested by the RSWG.  
Jääskeläinen et al.20 included both clinical and social outcomes using the RSWG definition of 
recovery with persistence for two years. They commented on the ‘high’ heterogeneity of recovery 
estimates (I2 statistic= 99.8%) and found a median annual recovery rate of 1.4%, with no statistically 
significant difference in outcome by gender. There was a significantly higher rate of recovery LMICs, 
as suggested by Warner and others (although this has been disputed by some 10 and rejoindered by 
others21,22). Their recovery figure for the 1976-1995 period (9.9%) was much lower than Warner’s. 
They reported, however, that the strictness of the definition of recovery used had no effect on 
outcome results. The difference between their results and Warner’s are almost certainly due to their 
use of a persistence criterion in the definition. We will examine the relevance of a persistence 
criterion in the analysis section of this paper.  
  Lally et al.23 included FEP studies only, and used Jääskeläinen’s criteria for recovery but also 
examined improvement persisting over one year. Studies that failed to meet the Jääskelänen 
criteria were designated ‘broad criteria’. The pooled rate of clinical remission for all included 
diagnoses was 58% (56% for schizophrenia). Only 23% achieved full recovery. They reported no 
difference in remission rates by study quality, duration of follow-up, study setting, or use of 
narrow/broad remission criteria/the RSWG criteria. Recovery rates were higher in Africa (73%; 2 
studies only), Asia (66%; 2 studies only), and North America (65%; 17 studies) compared with Europe 
and Australia. In the most recent period, 2005-2016, recovery rates remained higher but not 
significantly so. Miettunen 13 reviewed systematic reviews of schizophrenia outcomes and reported 
an overall recovery rate of 13.5% and also found higher rates of recovery in poorer countries. NeuRA 
14 reported a review of six reviews conducted through three search engines (all these engines are 
included in our searches). They suggest that the quality of the evidence in the six reviews is at best 
moderate, that the overall recovery rate for schizophrenia in the 21st century  has been between 13 
and 16%,  and that the five year outcome for first episode is 58% clinical recovery, but they do not 
provide pooled averages for social or employment outcomes.  
We do not believe that the existence of this marked heterogeneity should be a reason to 
cease all comparative outcome research. In our opinion, researchers should continue to strive to 
reduce heterogeneity and to use indicators where greater consensus can be achieved. Employment 
status is one such candidate. A contextualised measure of financial strain might be another. The 
advantage of the present review is not that it reduces heterogeneity but that it allows a meaningful 
longitudinal view because, by using the same methods as Warner, it compares like with like.  
Since the first edition of Warner’s book, there has been a substantial increase in outcome 
research: in first episode psychosis (FEP), in early onset, in intervention samples and, most recently, 
in high-risk groups.  This has led to intense interest in the role of duration of untreated 
psychosis.  This variable is excluded from the present review (as there is nothing in Warner’s  1985 & 
2004 editions to compare it with). Since Warner’s original work there has been a growing awareness 
of the need to incorporate other features of recovery other than simply clinical remission17,23-29 . 
Employment is considered as an outcome in some reviews, but pooled data are not given10.  None of 
the reviews (summarized in the Supplementary Material A) include employment status as an 
outcome indicator in spite of its growing relevance and evident support for its consideration. 30-35  
As indicated earlier, wherever the data was presented, we have included employment outcome in 
this review.  
The purpose of the present review is to assess the extent to which Warner’s conclusions, and the 
conclusions of subsequent reviews, hold in the twenty-first century. Are remission rates stable, are 
they influenced by different definitions of remission and by different persistence criteria, are they 
affected by duration of follow up or other study features? How do clinical, social and employment 
outcomes differ in MEP and FEP studies, and are outcomes better in LMICs? To explore the evidence 
supporting Warner’s hypothesis concerning the importance of changes in the political economy, we 
have taken the opportunity to look for any noticeable difference in outcomes for data gathered 
before and after the 2008 crash.  
Method  
We followed Warner’s methods as closely as possible. As in his original review, only 
observational/naturalistic studies were included, study samples comprised at least 80% individuals 
with diagnoses of schizophrenia, schizophreniform, and schizoaffective disorder (i.e., broadly 
defined “schizophrenia”) with at least 6 months follow-up (Warner included those of one year or 
over, but we adhered to the more recent RSWG criteria).  In studies where a “schizophrenia” sub-
sample of 30 or more cases was fully described independently within the paper, we used only those 
data.  In addition, if early intervention or first episode studies included persons with a schizophrenia 
diagnosis and reported these results separately, then the schizophrenia group results are also 
included in our analysis.  FEP is defined as patients who are making their first treatment contact for 
psychotic symptoms OR are in their first episode of psychosis AND do not meet diagnostic criteria for 
an affective disorder (i.e. only schizophrenia-spectrum diagnoses included).  
Exclusion criteria were:  
• Age < 18 years old at study inception (but not for FEP studies where no lower age limit was 
applied).    
• source not written in English language;  
• clinical trials;  
• primary diagnosis other than schizophrenia (e.g. bipolar disorder);  
• selected outpatient and hospital discharge samples;  
• retrospective studies;  
• cross-sectional studies;  
• small studies (n<25);  
• cognitive and neurological function only assessed;  
• data gathered entirely or mainly in the 20th century.  
We also excluded studies where outcome ratio data could not be computed (see also 
Hegarty 36). Where a study was reported in more than one paper using the same data, the paper with 
usable and latest results was included (as in Jääskeläinen et al.20). In some cases where different 
outcomes (clinical and functional) from the same study were reported in separate papers (e.g. 
Addington et al. 43,44) both outcomes were included in the results, but the total number of subjects 
was adjusted to avoid double counting. Where a research group reported single study results 
separately for MEP and FEP cases, we entered both sets of results into the analysis, but did not 
double count respondents. We examined four types of outcome: clinical; social; complete recovery 
(which we defined as meeting both RSWP and Warner criteria) and employment (measures of social 
recovery are listed in Supplementary Material B). Given Warner’s thesis regarding the influence of 
the political economy we felt it was important to consider social and employment outcomes 
(employed/not) as well as clinical outcome, and complete recovery (as defined above). In some 
studies, the only usable outcome data were on employment79. The abrupt contextual changes in the 
global economy in 2008 (the generally accepted date of the global financial crash) created an 
opportunity to assess any changes from pre to post crisis.  
RW and PH began the search and review process, using Warner’s inclusion and exclusion criteria 
and made decisions jointly whether to include or exclude studies. At this stage (2015-6) more than 
700 papers were under review. Warner’s untimely death occurred before the process could be 
completed. Searches were undertaken again in 2017-18 and updated in 2020.  
•         Search terms: terms schizo* OR psychos*s OR psychotic AND recovery OR outcome* OR 
remission OR longitudinal OR course OR follow-up in a title search. 
•         Period: 1 Jan 2000-30 June 2020  
•         Databases:  
•         Science Direct  
•         Proquest (Social Sciences Collection)  
•         PsycArticles  
•         Cinahl (Ebscohost)  
•         Medline (Ebscohost)  
•         Web of Science (Biosis, Core, Scielo)  
Decisions on study inclusion were undertaken in pairs between PH, AK, SA and LP. In all cases where 
it was possible the decisions were confirmed by reference to Warner’s own notes shared with PH in 
2016. In the event of disagreement, a third opinion was sought from one of the other authors of this 
paper.  
To explore any impact of the financial crash, we divided the studies into those where data 
collection was entirely completed before 2008, and those whose data was collected entirely after 
2008. Remaining studies where data collection included 2008 were assigned to the period in which 
the majority of data were gathered.  
We also divided the studies depending upon their definition of outcome and recovery. We 
contrasted studies using the RSWG definition of clinical remission17 and those that did not. The 
location of the study was examined categorising data collection areas into Europe, North America 
and the rest of the world (a catch-all necessitated by low numbers of studies). We further compared 
outcomes in first episode psychosis (FEP) or early intervention study samples with all outcomes in 
non FEP/Early Intervention studies, labelled various or multiple episodes of psychosis (MEP) (called 
‘mixed duration’ by Warner). Length of follow-up was divided into 6 months (our minimum), or 
longer than 6 months. Where follow-up was repeated at more than one time point, the final 
assessment was used. This enabled us to include the longest available outcomes whilst avoiding 
double counting.  
Statistical procedures  
Recovery estimates are presented as pooled averages or as medians. For change over time, 
we used the same year categories as Warner. For economic comparisons we used the per capita 
income statistics as recommended by Cohen et al. 10 based on the latest figures provided by the 
World Bank 37. Analysis by regions compared studies conducted in the USA, Europe and the rest of 
the world. For comparisons by definition of recovery we used the Andreasen et al. criteria (2005)17 
(RSWG) versus studies using other definitions. Warner did not include an explicit persistence 
criterion in his definition of recovery but others have done, and so we examine all the outcomes by 
the persistence criterion used in the included studies, using analysis of variance. In relation to study 
quality, we followed the MOOSE criteria for meta-analysis in observational studies38 and consulted 
subsequent relevant guidance 39-42.  
Variable distributions were checked. Skewed variables were transformed appropriately, for 
example the social/functional outcome variable. Annualised recovery rate was calculated by dividing 
the remission rate by the length of follow-up (see Jääskeläinen et al. 2013)20. Means of the 
independent continuous outcome variables were analysed in relation to the dependent variables 
using t-tests or one-way Anova, and relationships between continuous variables by correlational 
analysis. Heterogeneity was tested using the I2 statistic.  
Results  
A total of 47 studies 43-90 (full details are given in Supplementary Material B) met the inclusion 
criteria and provided data for year of study, definition of outcome, stage of illness, length of follow 
up (in all but one instance follow-up was 12 months or more) and region (Figure 1).  
   
   
   
   
   
   
  
   
Figure 1: Search strategy  
Some of these gave only functional or employment outcomes. In three instances the study 
reported separate data for two outcomes. Accordingly, 50 data sets were entered into the analysis. 
The number of studies that followed the Warner criteria for clinical remission was 43. The clinical 
results below are based on these 43 studies unless otherwise specified. In some other studies, data 
were presented in a format that could not be interpreted for our present purposes.  Such studies 
usually involved the use of predictive regression models, and raw outcome data were not reported. 
In all instances, we attempted to, but were unable to, access the raw data. Examples of the types of 
studies excluded are given in the Supplementary Material C.  
The total number of (unduplicated) participants is 13430 (FEP: 6049; MEP: 7381). Clinical 
outcome was reported in 43 papers (11048 participants), functional or social outcomes in 20 papers 
(5602 participants) and employment outcomes in 23 papers (9990 participants). Since we are 
interested in changes in the recent past, our outcomes are reported in table 1 alongside Warner’s 
(2004) results from the latter part of the 20th century i.e. 1945-2000 (derived from Warner 2004; 
Table 3.1 pages 64-76).  
Study quality 
There was no relationship between the quality rating and any of the outcome measures, 
including clinical outcomes (t=1.379 df 41 p=0.175; mean difference = 8.817; SE diff=6.394 95% CI -
4.095 to 21.730). The Jääskeläinen review20 found considerable heterogeneity in the recovery rate (I2 
statistic =99.8%) and we too found high heterogeneity in the clinical outcome variable in our 
included studies (I2 statistic = 97.1%).  
Definition used  
Most of the studies used the RSWG criteria but a very few added the duration requirement, 
some at 6 months, 61,67 some one year, 90 and others required two years. 78   A comparison between 
groups of studies that had no duration criterion (36%), or a criterion of six months (42%), or a 
criterion of twelve months or more (22%), showed no significant differences in any outcome.  The 
outcomes for those studies that used RSWG criteria compared to those using ‘other’ criteria also 
showed no differences. In all outcomes, the ‘other’ definitions had better outcomes by a few 
percentage points, with the exception of ARR which was higher in the RSWG studies (ARR 2.2 cf 1.9) 
but was not significant.  
Clinical and social outcomes and stage of illness  
Table 1 shows the mean (pooled average) outcomes in the original Warner work (from post-
World War Two to the end of the century) together with the 21st century results from the present 
review. Complete recovery improves significantly in the MEP group, but social recovery is not 
significantly improved in either MEP or FEP. The most striking feature is the significantly higher 
complete recovery rate (57%) in FEP studies in the present review.  
Table 1:  Complete and Social Recovery: Comparison of 20th and 21st Century Studies  
   Complete % (mean; sd)  Social % (mean; sd)  
MEP*  FEP**  MEP  FEP  
Warner (1945-2000) N=64  20.37 
(11.3)  
20.7 (11.52)  41.1 (16.6)  40.6 (17.7)  
Huxley et al. (2000-2020) N=43  37.75 
(14.9)  
57.14 (15.4)  43.5 (23.0)  47.3 (20.7)  
Note: FEP= First episode psychosis, MEP = Multi Episode Psychosis; *p<0.05, **p <0.001  
Warner presented the recovery data by decade, and Jääskeläinen et al.20 did the same. By 
their own account, the latter authors used a stricter definition of recovery. We reanalysed Warner’s 
data to obtain the median recovery rates of FEP and ME by decade and these are presented in Table 
2.  
Table 2: Comparison of Median (%) Recovery Rate by Decades  




Jääskeläinen et al. 
2013  
Pre 1941  18.5  29.0  13.0  
1941-1955  24.5  31.5  17.7  
1956-1975  21.0  19.0  16.9  
1976-1995  25.5  12.0  9.9  
After 1996  29.0  13.6  6.0  
  Note: Data derived from Warner 20042; Table 3.1 pages 64-76  
   
   
Our figures for the first two decades of the 21st century continue trend of improvement previously 
reported by Warner. Our median is 54.0% . This is consistent with the mean figures given  in Table 1. 
Similarly, our median for MEP is also considerably improved at 33.45 and is a return to the median 
levels Warner observed between 1941 and 1955. Possible reasons for these changes are considered 
in the discussion.  
Annualised recovery rate (ARR)  
Using the ARR as defined by Jääskeläinen and colleagues20, (who found a median ARR of 
1.4%) we found a median ARR of 2.2%. Warner’s median ARR for the last period in his review (1980 
to 2000) was 2.9. In our data, the ARR shows a trend towards significant reduction over time, 
reducing to 1.6 after the financial crash of 2008 from 2.2 before (t=1.85 df 40 p=0.07). The 
reduction is statistically significant for the MEP group (t=2.32 df18 p=0.03). 
Table 3 compares all the outcomes for the MEP and FEP groups in our review. Because ARR 
and social outcome were both skewed we used log-transformed variables. Clinical remission, the 
annualised recovery rate and employment are all significantly superior for the FEP group, but social 
outcome is not.  
Table 3: Multiple Episode compared to First Episode Outcomes  




95% CI  
Lower  Upper 
Employment  -
2.43  
36  0.020*  -13.70  5.65  -
25.16  
-2.26  
Clinical remission  -
4.61  





22  0.380  -0.79  0.08  -0.26  -0.11  




46  0.001**  -0.31  0.12  -0.55  -0.07  
Note: *p<0.05, **p <0.001  
   
Location  
While there is a trend for employment outcome rate to be better in the rest of the world 
(45% sd 19.9; 8 papers) than in Europe (38.6% sd 18.9; 19 papers) and North America (35.4% sd 24.6; 
5 papers) there is no statistically significant relationship between any of the outcomes and region. 
There was no difference in the regional annualised recovery rate.  This result holds for both FEP and 
MEP studies. Using RSWG studies only there are still no significant differences by region.  
Comparing the 5 LMIC countries with the HICs showed that only employment was 
significantly different (better in LMIC t=2.18 df 30 p=0.037).  
Sample characteristics (Sample size, % male, % follow up, length follow-up)  
There are no significant associations between these variable (sample size, gender 
distribution, percentage followed up and length of follow up) and any outcome measure. The results 
are the same in both the MEP and FEP groups.  
Measures used  
PANSS was the most commonly used clinical outcome measure (62.5% of studies). GAF was 
the most commonly used functional outcome measure (39.3% of studies). There are no differences 
in clinical, social, employment or ARR outcomes in either MEP or FEP cases when PANSS and GAF are 
used compared to the other measures used.  
Year of data collection  
In studies conducted after 2008, good clinical and employment outcomes both decline. 
Functional outcome improves, but the functional data are highly skewed. Although positive clinical 
outcome is reduced from a pooled average of 49% before 2008 to 45.6% after, this change is not 
significant. Employment outcome is markedly worse after the crash (employed 34.9%) than before 
(employed 42.3%) (as one would expect) but this is not statistically significant. These findings apply  
 to both the FEP and MEP groups.  
Discussion  
Our review has some limitations. The most significant of these is heterogeneity of methods 
and outcome criteria between studies. This is a limitation which is intrinsic to reviews of naturalistic 
outcome studies, and it has affected all of the previous reviews. It precludes over-confident 
conclusions or a claim of definitive findings, especially in those sub-analyses where the number of 
studies is small. Whilst most of our results are indicative only, they do shed light on the multifaceted 
nature of recovery and on important temporal trends.    
This review of 21st century studies tends to confirm one of Warner’s key assertions, that a 
significant proportion of people who receive a schizophrenia diagnosis make a good recovery. There 
are some significant new findings. Generally speaking, these do not reach statistical significance 
owing to wide confidence intervals, but they resonate with many other findings on the impact of 
poverty, employment and other social factors 90.  
Whilst we have found that rates of complete recovery have increased substantially for 
people experiencing a first episode of psychosis in the 21st century, not all of our findings are 
positive. Findings by both Warner and Jääskeläinen showed decreasing annualised rates of recovery 
over time and we have found a continuing decline in ARR since Warner’s review. Differences in 
method and criteria almost certainly account for differences in their figures, particularly the use of a 
persistence criterion by Jääskeläinen. Nonetheless, the trend is the same in all three reviews.  
People with multiple episodes fare much worse than people who respond well to 
intervention for FEP (Table 1). Whilst it has long been recognised that relapse increases the risk of 
subsequent relapse, something appears to have changed. It is reasonable to speculate that this 
might be due to changed priorities in mental health policy since the end of the era of de-
institutionalisation (roughly 1955-1995). High-income countries (HICs) have made huge efforts to 
improve outcomes from FEPs. There has been substantial investment in specialist FEP/early 
intervention services, which contrasts starkly with disinvestment, loss of research interest and, some 
would say, neglect of rehabilitation and other services for people with MEP. 91  
There is an apparent paradox that an improved rate of complete recovery has been 
accompanied by a deteriorating ARR. The same clinical and research focus on FEP in the UK and USA 
might account for this. It is possible that better early intervention on first presentation of psychosis 
results in an increasingly high proportion of those who will achieve recovery experiencing this 
immediately, with a consequent reduction in recovery rates for those who relapse, who 
predominate in the annualised sample. A similar explanation is unrelated to treatment. Overtime, 
changes in social attitudes may mean that  a history of a single episode of psychosis may have 
become less marginalising, say with respect to employment, but that recurrent episodes, with 
attendant disruption to employment and housing, have a much more marginalising effect, a poor 
social outcome then contributing to poor clinical outcome.  
A further temporal change is a trend towards better outcomes prior to the 2008 crash, and 
for this to decline somewhat afterwards. Both findings are compatible with Warner’s emphasis on 
the political economy as a key factor influencing people’s ability to recover.   Warner notes (pp38-
40) that when the business cycle goes into recovery, patients in the low income groups 
disproportionately pay the psychological price of adapting to new jobs, in new locations, with new 
colleagues. All of which result in new illnesses or the exacerbation of existing ones. 
   
There is a trend to better outcomes in the non-UK non-US studies, but this is hard to 
interpret.  The category includes data from LMICs and some HICs, and the number is very small. The 
finding is of interest, but cannot be taken to show that recovery rates are better in LMICs. More 
importance can be attached to the fact that, overall, participants in the non-UK non-US group 
probably had poorer access to treatment. If treatment accounted for improved outcomes, you 
would expect the trend in this group to be in the opposite direction to one we have found.   
The same caveats must attach to the finding of a trend towards better employment 
outcomes in non-UK non-US studies, but there may be an important factor relating to better but less 
formal employment opportunities in LMIC settings. Although we cannot say that outcomes in LMICs 
are better, our review lends no credence to the idea that LMIC outcomes are worse. Warner took 
the view that outcomes were better in the developing world, and our limited findings are congruent 
with other recent findings 13,20, 92 .    
Our findings of changes in outcomes over time, with possible attenuation of improvements 
in HICs after 2008 and outcomes probably no worse in LMICs (possible better) tend to suggest that 
Warner was right, and that social factors are key determinants of recovery. It may be argued that a 
definition of recovery that includes employment will inevitably become less common in hard times, 
but this misses the point. Recovery and context cannot be separated. As suggested above, sustained 
employment is a measure of recovery, but employment is also known to improve clinical outcomes.  
 There must be some caution about the impact of the 2008 crash. Doubtless its effects took 
time to work through. The collapse of the Lehman Brothers Bank (the first sign of problems) was in 
2006. Arguably, studies conducted shortly after 2008 were less affected by the crash than those 
reporting later. It is, of course, possible to make other assumptions and take other cut off points and 
the data are available for those who wish to do that. Also, it can be argued that the period since 
2008 is too short to reveal significant differences in all of the outcomes.  
Comparison of our findings and Warner’s original findings show significant improvements in 
rates of recovery FEP, with more disappointing results for MEP, especially post-2008. There appears 
to have been no real improvement in social outcomes for either FEP or MEP. Rates of recovery are 
lower when a length of recovery criterion is applied, but trends are unaffected. Taken with Warner’s, 
Miettunen’s 13 and Jääskeläinen’s 20 findings, there may be a consistent decline in annualised 
recovery rates decade by decade. The research synthesis literature has found no consistent 
increases in recovery when defined solely by changes in clinical symptoms. As the published data do 
not permit robust analysis of social or employment outcomes, there is a pressing need, noted by 
other authors, for improvements in the capture and reporting of clinical and social outcomes. A 
reduction in methodological heterogeneity of studies would be a major step forward, with 
adoption of standard definitions of functional recovery and social outcomes. Having said that, we 
were unable to show that the greater homogeneity produced by using the RSWG standard definition 
of recovery led to any differences in reported outcomes compared to other definitions.  
 Our understanding of functional outcomes would be improved if employment outcomes 
were disaggregated into meaningful categories of type, length, security of employment and 
remuneration rates. This is important for the evaluation of social interventions and system-wide 
service improvements. Warner would strongly approve of such a development. One could argue on 
the basis of this and other reviews, that a more profitable way forward might be to think in terms of 
outcome profiles based on several functional and clinical measures rather than conflating them as 
many definitions of ‘recovery’ do.  
To conclude, there is growing recognition that “outcome” is most meaningfully understood 
in terms of social parameters.  A new approach is needed that does not ignore the biological and 
psychological aspects of psychosis but does place both causation and intervention firmly in their 
social context. Psychosis is a disorder where onset, course and outcomes are profoundly affected by 
social factors. Recovery can only meaningfully be understood as a social phenomenon. 
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